Investigation of unique immune microenvironment of Primary CNS Lymphoma

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1120171

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

This study will investigate how the immune system responds to the development of brain lymphoma. It is expected that this lymphoma develops due to a defective immune response. It is unknown why the tumour is so effective at evading the immune response but if the hypothesis is correct, then the application of new drugs that stimulate the immune system to attack the lymphoma could lead to a marked improvement in survival without the need for toxic chemotherapy and radiation.

Funded Activity Details

Start Date: 01-01-2017

End Date: 01-01-2020

Funding Scheme: Early Career Fellowships

Funding Amount: $265,138.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Haematological Tumours

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

T cell immunity | T cell immunotherapy | central nervous system (CNS) | immune response | lymphoma

Related Links